Navigation Links
The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients

- Data Presented at the 11th International Myeloma Workshop -

NORTH HOLLYWOOD, Calif., and KOS, Greece, June 29, 2007 /PRNewswire/ -- The International Myeloma Foundation (IMF) -- supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians -- today said that updated statistics reported at the 11th International Myeloma Workshop in Greece demonstrate improved survival for a wide range of myeloma patients. Among the findings, in patients who had relapsed after one or more previous treatments:

    -- REVLIMID(R) (lenalidomide) plus the steroid dexamethasone showed an

       unprecedented median survival of nearly three years (35 months) for

       patients previously treated with multiple myeloma in updated data

       pooled from two large randomized controlled Phase III trials evaluating

       more than 700 patients from nearly 100 clinical sites worldwide.


    -- VELCADE(R) (bortezomib), combined with cyclophosphamide and prednisone

       in an open label Phase II trial evaluating 13 patients demonstrated an

       overall response rate of 93 percent. At one year, 100 percent of

       patients were alive.


    -- And combining VELCADE plus REVLIMID (with a steroid) showed a response

       rate of 68 percent in a pilot study of heavily pretreated patients.

"It was 15 years ago this month that my husband Brian Novis lost his battle with myeloma, and the progress since that time is truly remarkable," said Susie Novis, president and co-founder of the IMF. "Brian was diagnosed when he was just 33 years old and lived only four years past his diagnosis. Today we have multiple options for treatment, and for many patients survival is being measured in years, not months, with an excellent quality of life."

The International Myeloma Workshop brings together myeloma experts from all over the world to review the lates
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
Post Your Comments:
(Date:6/30/2015)... June 30, 2015 First Choice Wellness Care ... Astanza Duality and is the only clinic in the ... tattoo removal treatments. The practice has recently expanded their ... brand to showcase their focus in the procedure. They ... results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... JERUSALEM , June 30, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical Company focused on the ... the first patient has been screened in the Company,s ...  This U.S. based study will be performed under the ... the U.S. Food and Drug Administration (FDA). ...
(Date:6/30/2015)... 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... offering  of 40,229,886 units. Each unit consists of one ... warrant to purchase one share of common stock, and ... share of common stock, at a purchase price of ...
Breaking Medicine Technology:First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
... Company Focused on IND-Enabling Work with Protein Therapeutics that ... Modulate Alternative Pathway of Complement System, CAMBRIDGE, ... has initiated a corporate growth plan with the,appointment of ... of its headquarters in Cambridge, Mass. Dr. Celniker succeeds,Woodruff ...
... Nonin Medical, a leading innovator,of physiological monitoring solutions ... testing phase with its breakthrough technology to measure,regional ... is the continuous monitoring of the regional blood ... testing data and outcomes from an ongoing clinical ...
Cached Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2
(Date:6/30/2015)... ... , ... Red Hot & Blue Restaurants, Inc. took home the ... and was selected as “Best BBQ” in a Texas-based Living Magazine ... Blue President Randy McCann said, “Everyone knows Red Hot & Blue serves smokin’ fresh ...
(Date:6/30/2015)... ... June 30, 2015 , ... Independence Day weekend is more than just fireworks ... kick off of July as National Hot Dog Month. Americans are expected to eat ... time of the year and enough to stretch from Washington D.C. to Los Angeles ...
(Date:6/30/2015)... ... 2015 , ... Board certified otolaryngologist Dr. Marcelo B. Antunes ... , Dr. Antunes is a fellowship trained facial plastic surgeon with ... to performing cosmetic and reconstructive surgery on the face, he enjoys treating patients ...
(Date:6/30/2015)... ... ... The United Nations Foundation’s Universal Access Project, in partnership with Planned Parenthood Federation ... today. Why We Care Youth serves as a platform for young people living in ... to them, and why U.S. policymakers should care about expanding access around the world. ...
(Date:6/30/2015)... ... 30, 2015 , ... NJ Top Dentist, Dr. Susan Goldfarb, had a very ... Course for members of the Bergen County Dental Society. She does this every ... recommendations for Healthcare Providers. Life Support from Hackensack Hospital provided the instructors and ...
Breaking Medicine News(10 mins):Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 2Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 3
... BEIJING, Nov. 19 /PRNewswire-Asia-FirstCall/ -- China Medical,Technologies, ... device company that develops, manufactures and markets advanced,in-vitro diagnostic products, ... ended September 30, 2009 ("2Q FY2009"). The,Company,s 2009 fiscal ... 2Q FY2009 Highlights, -- Revenues ...
... Conn., Nov. 18 AmeriCares and Boeing today delivered an ... of people are still reeling from the devastation caused by ... and other storms have been slow to recede, creating a ... homeless and living in crowded evacuation centers, the threat of ...
... 18 A "model" tobacco cessation benefit offered ... drop in smoking rates in only two and a ... in heart attacks, hospitalizations for asthma and COPD, and ... the Massachusetts Tobacco Cessation and Prevention Program (MTCP) found ...
... pain on the dance floor , CHICAGO, Nov. 18 ... dancing the night away can take a toll on feet and ... can stop the show, as witnessed this season on the popular ... the American College of Foot and Ankle Surgeons, the most common ...
... restaurants onto outdoor patios, but a new University of Georgia ... Prevention suggests that these outdoor smoking areas might be creating ... the first to assess levels of a nicotine byproduct known ... levels up to 162 percent greater than in the control ...
... be continuous, infection state unclear , WEDNESDAY, Nov. 18 (HealthDay ... lesions, never truly goes into a dormant state, new research ... not causing an outbreak, the virus is shedding tiny bits ... did not specifically address whether or not the very small ...
Cached Medicine News:Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 2Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 3Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 4Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 5Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 6Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 7Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 8Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 9Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 10Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 11Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 12Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 13Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 14Health News:AmeriCares and Boeing Deliver Emergency Relief Supplies to the Philippines 2Health News:Massachusetts' 'Model' Tobacco Cessation Benefit Spurs Unprecedented Drop in Smoking Rates, Heart Attacks, Asthma, and Birth Complications 2Health News:Massachusetts' 'Model' Tobacco Cessation Benefit Spurs Unprecedented Drop in Smoking Rates, Heart Attacks, Asthma, and Birth Complications 3Health News:Healthy Feet Make the Best Dancing Feet 2Health News:Study raises concerns about outdoor second-hand smoke 2Health News:Genital Herpes May Never Go Dormant 2Health News:Genital Herpes May Never Go Dormant 3
... AggRAM, for platelet aggregation and ristocetin ... with the power of Windows-based software ... to two AggRAM modules can be ... computer so you can configure your ...
The Multiple Perfusion set provides simultaneous perfusion of the aortic root and up to three or more vein grafts. The set features an inlet port with female luer and clamp attached to an adapter whi...
The Aortic Root Cannulae With Vent Line are flanged, with radiopaque tips; two side holes in tip....
The KAVD Venous Cannula is the first of its kind. It is a combination of cannulae/venous line designed to "bridge the gap between the patient and the Medtronic Resting Heart System circuit....
Medicine Products: